132 related articles for article (PubMed ID: 33625349)
1. Solitary brain metastasis after recurrent adenocarcinoma of the prostate.
Rodriguez-Homs M; Wiesen B; Rizeq M; Randau C; Lloyd GL
Can J Urol; 2021 Feb; 28(1):10565-10567. PubMed ID: 33625349
[TBL] [Abstract][Full Text] [Related]
2. Intracranial treatment for solitary prostatic adenocarcinoma brain metastasis is curative.
Sweets T; Bracken RB; Geisler EJ; Warnick R
Urology; 2009 Mar; 73(3):681.e7-9. PubMed ID: 18502485
[TBL] [Abstract][Full Text] [Related]
3. Response of cerebral metastasis secondary to prostate cancer to primary androgen suppression.
Bhuva NJ; Ward D; Hughes R
BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22789555
[TBL] [Abstract][Full Text] [Related]
4. Brain metastasis as a sole recurrence of prostate cancer after total prostatectomy.
Hayashi T; Igarashi K; Tanizawa A; Terada Y; Sekine H
Urol Int; 1998; 60(2):121-3. PubMed ID: 9563153
[TBL] [Abstract][Full Text] [Related]
5. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
6. Cystic solitary intracerebral metastasis from prostate adenocarcinoma.
Behrens B; Husain MM; Schmidley JW
Neuroradiology; 2001 Feb; 43(2):162-4. PubMed ID: 11326565
[TBL] [Abstract][Full Text] [Related]
7. Brain metastases from prostate adenocarcinoma.
Castro Gómez JE; Anido Herranz U; Carballo Castro A; Gómez Caamaóo A; León Mateos LA; Porto Vázquez C; López López R
Clin Transl Oncol; 2009 Jan; 11(1):63-4. PubMed ID: 19155207
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
Zagars GK; Pollack A; von Eschenbach AC
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
[TBL] [Abstract][Full Text] [Related]
9. Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy.
Sartor CI; Strawderman MH; Lin XH; Kish KE; McLaughlin PW; Sandler HM
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):941-7. PubMed ID: 9276358
[TBL] [Abstract][Full Text] [Related]
10. Brain metastasis from prostate cancer: a case report.
Zhang X; Tsukuda F; Yamamoto N; Takenaka I
Int J Urol; 1997 Sep; 4(5):519-21. PubMed ID: 9354958
[TBL] [Abstract][Full Text] [Related]
11. Brain metastasis: an unusual complication from prostatic adenocarcinoma.
Fervenza FC; Wolanskyj AP; Eklund HE; Richardson RL
Mayo Clin Proc; 2000 Jan; 75(1):79-82. PubMed ID: 10630761
[TBL] [Abstract][Full Text] [Related]
12. Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients.
Romesser PB; Pei X; Shi W; Zhang Z; Kollmeier M; McBride SM; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):59-67. PubMed ID: 29254782
[TBL] [Abstract][Full Text] [Related]
13. Prostate Cancer Brain Metastases: A Single-Institution Experience.
Bhambhvani HP; Greenberg DR; Srinivas S; Hayden Gephart M
World Neurosurg; 2020 Jun; 138():e445-e449. PubMed ID: 32147556
[TBL] [Abstract][Full Text] [Related]
14. An isolated pulmonary metastasis in prostate cancer.
Hofland CA; Bagg MD
Mil Med; 2000 Dec; 165(12):973-4. PubMed ID: 11149072
[TBL] [Abstract][Full Text] [Related]
15. Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial.
Cheung E; Pinski J; Dorff T; Groshen S; Quinn DI; Reynolds CP; Maurer BJ; Lara PN; Tsao-Wei DD; Twardowski P; Chatta G; McNamara M; Gandara DR
Clin Genitourin Cancer; 2009 Jan; 7(1):43-50. PubMed ID: 19213668
[TBL] [Abstract][Full Text] [Related]
16. Large cystic intraparenchymal brain metastasis from prostate cancer.
Bland LI; Welch WC; Okawara SH
Neuroradiology; 1992; 34(1):70-2. PubMed ID: 1553042
[TBL] [Abstract][Full Text] [Related]
17. Biopsy-proven brain metastases from prostate cancer: a series of four cases with review of the literature.
Gzell CE; Kench JG; Stockler MR; Hruby G
Int Urol Nephrol; 2013 Jun; 45(3):735-42. PubMed ID: 23666549
[TBL] [Abstract][Full Text] [Related]
18. Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis.
Gettman MT; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
Urology; 1998 Jan; 51(1):79-85. PubMed ID: 9457293
[TBL] [Abstract][Full Text] [Related]
19. Clinical performance of
Kranzbühler B; Nagel H; Becker AS; Müller J; Huellner M; Stolzmann P; Muehlematter U; Guckenberger M; Kaufmann PA; Eberli D; Burger IA
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):20-30. PubMed ID: 29032394
[TBL] [Abstract][Full Text] [Related]
20. Brain metastases: a rare initial presentation of prostate cancer.
Grenader T; Shavit L; Lossos A; Pizov G; Wygoda M
Int Urol Nephrol; 2007; 39(2):537-9. PubMed ID: 17308872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
